•
Jun 30, 2022

Summit Therapeutics Q2 2022 Earnings Report

Total Revenue
$235K
Previous year: $57K
+312.3%
EPS
-$0.17
Previous year: -$0.27
-37.0%
Gross Profit
$193K
Previous year: $57K
+238.7%
Cash and Equivalents
$57.3M
Previous year: $103M
-44.5%
Free Cash Flow
-$19.5M
Previous year: -$19.3M
+1.0%
Total Assets
$95.7M
Previous year: $146M
-34.2%

Summit Therapeutics

Summit Therapeutics